Results 61 to 70 of about 592,747 (102)
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos +5 more
wiley +1 more source
Comparative efficacy of oral administrated afoxolaner (NexGard™) and fluralaner (Bravecto™) with topically applied permethrin/imidacloprid (Advantix®) against transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs [PDF]
BACKGROUND : The ability of the topical spot-on Advantix® (50 % permethrin/10 % imidacloprid) to prevent transmission of Ehrlichia canis by infected Rhipicephalus sanguineus ticks to dogs has previously been reported.
Erasmus, Heidi +9 more
core +1 more source
This study evaluates the pharmacokinetics of milbemycin oxime in Pekingese dogs after oral (tablet and nanoemulsion) and intravenous administration. The nanoemulsion showed faster absorption, higher peak concentration, and near‐complete bioavailability (99.26%) compared to tablets (51.44%), suggesting its potential as a superior alternative for ...
Ze‐En Li +7 more
wiley +1 more source
Esafoxolaner, a purified enantiomer of afoxolaner with insecticidal and acaricidal properties, is combined with eprinomectin and praziquantel in NexGard® Combo, a novel topical endectoparasiticide product for cats.
Prullage Joe +5 more
doaj +1 more source
Background – Demodicosis is common in dogs and is caused by proliferation of commensal Demodex canis mites. Objective – To evaluate the efficacy of sarolaner in combination with moxidectin and pyrantel (SMP) for the treatment of generalised demodicosis in dogs.
Csilla Becskei +5 more
wiley +1 more source
Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs
Twelve healthy dogs were included in this laboratory efficacy study. Six dogs were randomly allocated based on body weight to an untreated control group and six to an afoxolaner (NexGard®) treated group.
Perier Nadège +5 more
doaj +1 more source
NexGard® Combo, a novel topical endectoparasiticide formulation for cats combining esafoxolaner, eprinomectin and praziquantel, for the treatment of internal and external parasite infestations, including arthropods, nematodes and cestodes, was tested for
Prullage Joe +3 more
doaj +1 more source
Consequences of repeated sarcoptic mange outbreaks in an endangered mammal population
Diseases and parasites are important drivers of population dynamics in wild mammal populations. Small and endangered populations that overlap with larger, reservoir populations are particularly vulnerable to diseases and parasites, especially in ecosystems highly influenced by climate change.
Johan Wallén +5 more
wiley +1 more source
Effective treatment with afoxolaner (NexGard) of Trixacarus caviae in a pet guinea pig
One female guinea pig was presented with dermatological problems and was confirmed to be infested by Trixacarus caviae mites. The animal was treated with a single oral dose of 2.50 mg/kg afoxolaner, with the complete remission of clinical signs and no mites at the microscopic examination after 4 weeks.
Georgiana Deak +5 more
wiley +1 more source
Detection of Anaplasma phagocytophilum in an inflammatory pericardial effusion of a dog
Abstract An 11‐year‐old female spayed German Wirehaired Pointer with a 1‐week history of lethargy, hyporexia, diarrhea, and coughing presented with pericardial effusion causing cardiac tamponade. An echocardiogram revealed no structural cause for pericardial effusion.
Betsy K. Murdock +4 more
wiley +1 more source

